Panitumumab Skin Toxicity Prevention Trial

NCT03167268 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Metastatic
Skin Toxicity

Interventions

DRUG: Lycopene
OTHER: Placebo

Sponsor

Ospedale San Carlo Borromeo